Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Wenbing Dai Hua Zhang |
| Publication date | April 13, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |